Cargando…
Insulin‐like growth factor 2 expression in prostate cancer is regulated by promoter‐specific methylation
Deregulation of the insulin‐like growth factor (IGF) axis and dysbalance of components of the IGF system as potential therapeutic targets have been described in different tumor types. IGF2 is a major embryonic growth factor and an important activator of IGF signaling. It is regulated by imprinting i...
Autores principales: | Küffer, Stefan, Gutting, Tobias, Belharazem, Djeda, Sauer, Christian, Michel, Maurice S., Marx, Alexander, Trojan, Lutz, Ströbel, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792735/ https://www.ncbi.nlm.nih.gov/pubmed/29239100 http://dx.doi.org/10.1002/1878-0261.12164 |
Ejemplares similares
-
Relaxed imprinting of IGF2 in peripheral blood cells of patients with a history of prostate cancer
por: Belharazem, Djeda, et al.
Publicado: (2012) -
Functional apoptosis profiling identifies MCL-1 and BCL-xL as prognostic markers and therapeutic targets in advanced thymomas and thymic carcinomas
por: Müller, Denise, et al.
Publicado: (2021) -
Molecular pathology of thymomas: implications for diagnosis and therapy
por: Marx, Alexander, et al.
Publicado: (2021) -
WNT4 overexpression and secretion in thymic epithelial tumors drive an autocrine loop in tumor cells in vitro
por: Zhang, Xiaonan, et al.
Publicado: (2022) -
cFLIP overexpression in T cells in thymoma-associated myasthenia gravis
por: Belharazem, Djeda, et al.
Publicado: (2015)